Perioperative transfusion of packed red blood cells (PRBC) has been associated with negative side effects. We hypothesized that a majority of transfusions in our series of patients who underwent pancreaticoduodenectomy (PD) were unnecessary. A retrospective analysis was performed to determine whether transfusions were indicated based on pre-determined criteria, and the impact of perioperative transfusions on postoperative outcomes was assessed.
Our prospectively maintained database was queried for patients who underwent PD between 2004 and 2011. 200 patients were divided into Cohort 1 (no transfusion) and Cohort 2 (transfusion). Rates of various graded 90-day postoperative complications were compared. Categorical values were compared according to the Common Terminology Criteria for Adverse Events. All cases involving intraoperative blood transfusion were reviewed for associated blood loss, intraoperative vital signs, urine output, hemoglobin values, and presence or absence of EKG changes to determine whether the transfusion was indicated based on these criteria.
There were 164 patients (82%) in Cohort 1 (no transfusion) and 36 patients (18%) in Cohort 2 (transfused). Both groups had similar demographics. Patients in Cohort 2 had lesser median preoperative values of hemoglobin (12.3 vs 13.1, P = .002), a greater incidence of vein resection (33% vs 16%, P = .021), longer operative times (518 vs 440 minutes, P < .0001), a greater estimated blood loss (850 vs 300 mL, P < .001), and greater intraoperative fluid resuscitation (6,550 vs 5,300 mL, P = .002). Ninety-day mortality was similar between the 2 groups (3% vs 1%, P = .328). Patients in Cohort 2 (transfused) had increased rates of delayed gastric emptying (36% vs 20%, P = .031), wound infection (28% vs 7%, P = .031), pulmonary complications (6% vs 0%, P = .032), and urinary retention (6% vs 0%, P = .032). A greater incidence of any complication of grade II severity (67% vs 35%, P = .0005) or grade III severity (36% vs 17%, P = .010) was also noted in Cohort 2. Of the 33 intraoperative transfusions, 15 (46%) did not meet any of the predetermined criteria: intraoperative hypotension (<90/60 mmHg), tachycardia (>110 beats per minute), low urine output (<10 mL/hour), decreased oxygen saturation (<95%), excessive blood loss (>1,000 mL), EKG changes, and low hemoglobin (<7.0 g/dL).
Perioperative transfusions among patients with PD were associated with increased rates of various postoperative complications. A substantive portion (∼46%) of perioperative transfusions in this patient population did not meet predetermined criteria, indicating a potential opportunity for improved blood product use. Further prospective studies are required to determine whether the implementation of these criteria may a positive impact on perioperative outcomes.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma.Ann Surg Oncol. 2011; 5: 1327-1334
- Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.Am J Surg. 1991; 161: 120-125
- Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas.Am Surg. 1999; 65: 618-624
- Pancreaticoduodenectomy: a 20-year experience in 516 patients.Arch Surg. 2004; 139: 718-727
- Prognostic factors after resection of pancreatic cancer.World J Surg. 2009; 33: 104-110
- Algorithms for evaluating the appropriateness of blood transfusion.Transfusion. 1989; 29: 298-303
- The necessary and the unnecessary transfusion: A critical review of reported appropriateness rates and criteria for red cell transfusions.Transfusion. 1994; 34: 110-115
- Evaluation of the appropriateness of blood and blood product transfusion using preset criteria.Transfusion. 1989; 29: 473-476
- Unnecessary blood transfusions in elective colorectal cancer surgery.Transfusion. 1985; 25: 113-115
- Practice guidelines for perioperative blood transfusion and adjuvant therapies. An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies.Anesthesiology. 2006; 105: 198-208
- Postoperative pancreatic fistula: An international study group (ISGPF) definition.Surgery. 2005; 138: 8-13
- Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS).Surgery. 2007; 142: 761-768
- Intraoperative transfusion of 1 U to 2U packed red blood cell is associated with increased 30 mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients.J Am Coll Surg. 2008; 208: 931-937
- Effect of blood transfusions on colonic malignancy recurrent rate.Lancet. 1982; 2: 662
- Blood transfusion and lung cancer recurrence.Cancer. 1988; 62: 606-610
- Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer.Ann Thorac Surg. 1989; 47: 346-351
- Blood transfusion and survival following surgery for prostatic carcinoma.Br J Surg. 1990; 77: 140-142
- Blood transfusion and the prognosis of patients with gastric cancer.J Surg Oncol. 1989; 42: 113-116
- Historical review of pancreaticoduodenectomy.Am J Surg. 1991; 161: 219-225
- Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy?.World J Surg. 2002; 26: 487-492
- Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas.Br J Surg. 2007; 94: 466-472
- Prognostic indicators for survival after resection of pancreatic adenocarcinoma.Am J Surg. 1993; 165: 68-73
- Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma.HPB (Oxford). 2007; 9: 472-477
- Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy.HPB (Oxford). 2010; 12: 465-471
- The 2009 national blood collection and utilization survey report.U.S. Department of Health and Human Services, Washington, DC2011
- One thousand consecutive pancreaticoduodenectomies.Ann Surg. 2006; 244: 10-15
- Blood transfusions and postoperative wound infection.Surgery. 1993; 113: 603-607
- Blood transfusion-induced immunomodulation.Anesth Analg. 1996; 82: 187
- Documenting and correcting inappropriate use of blood components. Improving transfusion practice: The role of quality assurance.American Association of Blood Banks, Arlington, VA1989: 21
Accepted: June 21, 2013
© 2013 Mosby, Inc. Published by Elsevier Inc. All rights reserved.